Taurian MPS Ltd.
•₹ 451.35-1.29%
2026-08-21
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 40.4%
- Company has a healthy return on capital (ROCE) of 33.4%
- Operating margins have improved to 20.5% from 9.5%
- Company comfortably covers its interest (12.0x coverage)
- Company maintains a comfortable, low leverage position
CONS
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.00x)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | THEJO | 2124.60 | 41.15 | 2304.66 | 0.24 | 15.23 | 56.09 | 177.61 | 31.02 | 21.79 | 14.23 |
| 2. | SOUTHWEST | 217.30 | 17.76 | 709.52 | 0.00 | 9.34 | 288.51 | 61.68 | 53.36 | 13.57 | 26.33 |
| 3. | TAURIAN | 449.60 | 0.00 | 399.39 | 0.00 | — | — | — | — | 39.80 | — |
| 4. | AHLADA | 40.82 | 0.00 | 52.74 | 0.00 | 1.75 | 203.29 | 240.26 | 778.98 | 2.69 | 13.52 |
| 5. | TMTINDIA | 8.45 | 0.00 | 4.19 | 0.00 | -0.05 | 36.25 | 0.00 | — | -110.50 | — |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 4 | 11 | 38 | 74 | |
| 4 | 9 | 29 | 58 | |
| Operating Profit | 0 | 2 | 15 | 15 |
| OPM % | 10 | 21 | 39 | 21 |
| Other Income | 1 | 0 | 7 | 0 |
| Interest | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 1 | 1 | 1 |
| -2 | -0 | 13 | 13 | |
| Tax % | 1 | 1,003 | 10 | 25 |
| Net Profit | -2 | 0 | 11 | 9 |
| EPS | -4 | 0 | 19 | 15 |
| Dividend Payout % | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 |
| Adjusted EPS | -4 | 0 | 19 | 15 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 |
| Adjusted EPS | -4 | 0 | 19 | 15 |
Mar 2022
- 4
- 4
- Operating Profit
- 0
- OPM %
- 10
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- -2
- Tax %
- 1
- Net Profit
- -2
- EPS
- -4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -4
Mar 2023
- 11
- 9
- Operating Profit
- 2
- OPM %
- 21
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- -0
- Tax %
- 1,003
- Net Profit
- 0
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2024
- 38
- 29
- Operating Profit
- 15
- OPM %
- 39
- Other Income
- 7
- Interest
- 1
- Depreciation
- 1
- 13
- Tax %
- 10
- Net Profit
- 11
- EPS
- 19
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 19
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 19
Mar 2025
- 74
- 58
- Operating Profit
- 15
- OPM %
- 21
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 13
- Tax %
- 25
- Net Profit
- 9
- EPS
- 15
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 15
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 15
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 167%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 40%
- Last Year:
- 35%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| LIABILITIES | - | - | - | - |
| Equity Capital | 6 | 6 | 6 | 6 |
| 2 | 2 | 13 | 28 | |
| 10 | 12 | 7 | 9 | |
| Trade Payables | 0 | 4 | 10 | 21 |
| 3 | 5 | 3 | 9 | |
| Total Liabilities | 22 | 29 | 39 | 73 |
| ASSETS | - | - | - | - |
| 11 | 9 | 7 | 13 | |
| 3 | 9 | 12 | 26 | |
| 0 | 0 | 17 | 30 | |
| 8 | 11 | 3 | 4 | |
| Total Assets | 22 | 29 | 39 | 73 |
| Total Debt | 12 | 14 | 7 | 9 |
| Net Working Capital | -1 | 1 | 12 | 22 |
| Contingent Liabilities | 0 | 3 | 3 | 3 |
| Book Value per Share | 12.92 | 13.29 | 32.16 | 53.62 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 12 | 14 | 7 | 9 |
| Net Working Capital | -1 | 1 | 12 | 22 |
| Contingent Liabilities | 0 | 3 | 3 | 3 |
| Book Value per Share | 12.92 | 13.29 | 32.16 | 53.62 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2022
- Equity Capital
- 6
- 2
- 10
- Trade Payables
- 0
- 3
- Total Liabilities
- 22
- 11
- 3
- 0
- 8
- Total Assets
- 22
- Total Debt
- 12
- Net Working Capital
- -1
- Contingent Liabilities
- 0
- Book Value per Share
- 12.92
- Face Value
- 10.00
- Total Debt
- 12
- Net Working Capital
- -1
- Contingent Liabilities
- 0
- Book Value per Share
- 12.92
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 6
- 2
- 12
- Trade Payables
- 4
- 5
- Total Liabilities
- 29
- 9
- 9
- 0
- 11
- Total Assets
- 29
- Total Debt
- 14
- Net Working Capital
- 1
- Contingent Liabilities
- 3
- Book Value per Share
- 13.29
- Face Value
- 10.00
- Total Debt
- 14
- Net Working Capital
- 1
- Contingent Liabilities
- 3
- Book Value per Share
- 13.29
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 6
- 13
- 7
- Trade Payables
- 10
- 3
- Total Liabilities
- 39
- 7
- 12
- 17
- 3
- Total Assets
- 39
- Total Debt
- 7
- Net Working Capital
- 12
- Contingent Liabilities
- 3
- Book Value per Share
- 32.16
- Face Value
- 10.00
- Total Debt
- 7
- Net Working Capital
- 12
- Contingent Liabilities
- 3
- Book Value per Share
- 32.16
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 6
- 28
- 9
- Trade Payables
- 21
- 9
- Total Liabilities
- 73
- 13
- 26
- 30
- 4
- Total Assets
- 73
- Total Debt
- 9
- Net Working Capital
- 22
- Contingent Liabilities
- 3
- Book Value per Share
- 53.62
- Face Value
- 10.00
- Total Debt
- 9
- Net Working Capital
- 22
- Contingent Liabilities
- 3
- Book Value per Share
- 53.62
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 1 | -1 | 1 | 0 | |
| Cash from Investing | 2 | 0 | 7 | -7 |
| Cash from Financing | -4 | 2 | -8 | 6 |
| -0 | 0 | -0 | 0 | |
| Free Cash Flow | 1 | -1 | 1 | -4 |
| OCF / Net Profit | -0.58 | -6.67 | 0.09 | 0.05 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
| OCF / Net Profit | -0.58 | -6.67 | 0.09 | 0.05 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 |
Mar 2022
- 1
- Cash from Investing
- 2
- Cash from Financing
- -4
- -0
- Free Cash Flow
- 1
- OCF / Net Profit
- -0.58
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.58
- Cumulative 5-Year FCF
- 0
Mar 2023
- -1
- Cash from Investing
- 0
- Cash from Financing
- 2
- 0
- Free Cash Flow
- -1
- OCF / Net Profit
- -6.67
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -6.67
- Cumulative 5-Year FCF
- 0
Mar 2024
- 1
- Cash from Investing
- 7
- Cash from Financing
- -8
- -0
- Free Cash Flow
- 1
- OCF / Net Profit
- 0.09
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.09
- Cumulative 5-Year FCF
- 0
Mar 2025
- 0
- Cash from Investing
- -7
- Cash from Financing
- 6
- 0
- Free Cash Flow
- -4
- OCF / Net Profit
- 0.05
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.05
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| PER SHARE | - | - | - | - |
| EPS (₹) | -3.90 | 0.37 | 18.87 | 14.85 |
| Book Value (₹) | 12.92 | 13.29 | 32.16 | 53.62 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | -1.23 | 2.50 | 20.91 | 16.96 |
| PROFITABILITY | - | - | - | - |
| Operating Margin % | 9.52% | 21.09% | 21.65% | 20.51% |
| Net Margin % | -60.60% | 2.06% | 30.11% | 12.92% |
| ROE % | -30.16% | 2.84% | 83.01% | 35.44% |
| ROCE % | -6.37% | 4.87% | 55.54% | 39.80% |
| -10.87% | 0.89% | 33.45% | 16.93% | |
| EFFICIENCY | - | - | - | - |
| Debtor Days | 422 | 189 | 113 | 116 |
| Inventory Days | 308 | 200 | 101 | 95 |
| Payable Days | 88 | 164 | 147 | 126 |
| 642 | 225 | 67 | 85 | |
| FINANCIAL HEALTH | - | - | - | - |
| Debt to Equity (x) | 1.50x | 1.77x | 0.37x | 0.27x |
| Interest Coverage (x) | -1.08x | 0.98x | 14.69x | 11.99x |
| 0.89x | 1.04x | 1.60x | 1.57x | |
| GROWTH | - | - | - | - |
| Revenue Growth % | 0.00% | 180.57% | 247.26% | 95.59% |
| Operating Profit Growth % | 0.00% | 521.33% | 544.70% | 3.61% |
| Net Profit Growth % | 0.00% | 109.54% | 4973.60% | -16.10% |
| 0.00% | 0.00% | 4973.60% | -21.29% | |
| VALUATION | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.89x | 1.01x |
Mar 2022
- EPS (₹)
- -3.90
- Book Value (₹)
- 12.92
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -1.23
- Operating Margin %
- 9.52%
- Net Margin %
- -60.60%
- ROE %
- -30.16%
- ROCE %
- -6.37%
- -10.87%
- Debtor Days
- 422
- Inventory Days
- 308
- Payable Days
- 88
- 642
- Debt to Equity (x)
- 1.50x
- Interest Coverage (x)
- -1.08x
- 0.89x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 0.37
- Book Value (₹)
- 13.29
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.50
- Operating Margin %
- 21.09%
- Net Margin %
- 2.06%
- ROE %
- 2.84%
- ROCE %
- 4.87%
- 0.89%
- Debtor Days
- 189
- Inventory Days
- 200
- Payable Days
- 164
- 225
- Debt to Equity (x)
- 1.77x
- Interest Coverage (x)
- 0.98x
- 1.04x
- Revenue Growth %
- 180.57%
- Operating Profit Growth %
- 521.33%
- Net Profit Growth %
- 109.54%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 18.87
- Book Value (₹)
- 32.16
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 20.91
- Operating Margin %
- 21.65%
- Net Margin %
- 30.11%
- ROE %
- 83.01%
- ROCE %
- 55.54%
- 33.45%
- Debtor Days
- 113
- Inventory Days
- 101
- Payable Days
- 147
- 67
- Debt to Equity (x)
- 0.37x
- Interest Coverage (x)
- 14.69x
- 1.60x
- Revenue Growth %
- 247.26%
- Operating Profit Growth %
- 544.70%
- Net Profit Growth %
- 4973.60%
- 4973.60%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.89x
Mar 2025
- EPS (₹)
- 14.85
- Book Value (₹)
- 53.62
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 16.96
- Operating Margin %
- 20.51%
- Net Margin %
- 12.92%
- ROE %
- 35.44%
- ROCE %
- 39.80%
- 16.93%
- Debtor Days
- 116
- Inventory Days
- 95
- Payable Days
- 126
- 85
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- 11.99x
- 1.57x
- Revenue Growth %
- 95.59%
- Operating Profit Growth %
- 3.61%
- Net Profit Growth %
- -16.10%
- -21.29%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 1.01x
Documents
Announcements
Nothing filed yet.
Annual Reports
Nothing filed yet.
Credit Ratings
Nothing filed yet.
Concalls
Nov 2025